Global Minimally Invasive Surgical Devices Market Poised to Reach USD 53.26 Billion by 2032, Driven by Rising Chronic Diseases and Technological Advancements

The global minimally invasive surgical devices market is growing at a CAGR of 7.13% during the forecast period from 2025 to 2032.
The global minimally invasive surgical (MIS) devices market is set to experience strong and sustained growth over the coming years, expanding from USD 30,798.01 million in 2024 to USD 53,259.85 million by 2032, according to recent industry analyses. This reflects a compound annual growth rate (CAGR) of 7.13% during 2025-2032, highlighting the rapid pace of innovation and adoption across surgical specialties worldwide.

Request a Sample Now and explore market forecasts, segmentation, and competitive strategies shaping the MIS devices industry @ Global Minimally Invasive Surgical Devices Market [https://www.delveinsight.com/report-store/minimally-invasive-surgical-mis-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Minimally Invasive Surgical Devices Market Overview and Growth Drivers

Minimally invasive surgical devices are transforming the global healthcare landscape by enabling procedures that involve smaller incisions, reduced trauma, faster recovery, and fewer complications compared to traditional open surgeries. This paradigm shift is being driven by a confluence of factors:

* Rising burden of chronic diseases - Conditions such as cancer, cardiovascular disorders, diabetes, and obesity are fueling demand for MIS interventions. Procedures like laparoscopic tumor resections, robotic-assisted cardiac surgeries, and bariatric interventions are becoming increasingly standard.
* Technological innovations - Breakthroughs in robotic-assisted systems, AI-enabled visualization, and advanced electrosurgical instruments are enhancing precision, reducing operating times, and improving clinical outcomes.
* Growing patient preference - With shorter hospital stays, reduced postoperative pain, and minimal scarring, patients are increasingly opting for MIS procedures, prompting hospitals and ambulatory centers to invest in advanced MIS technologies.

As a result, MIS devices are being deployed across diverse specialties including oncology, orthopedics, gynecology, cardiology, gastroenterology, and neurology, making them indispensable to modern surgical care.

Download the full Minimally Invasive Surgical Devices Market Report to uncover detailed growth insights, key drivers, and future opportunities @ Minimally Invasive Surgical Devices Market Dynamics [https://www.delveinsight.com/sample-request/minimally-invasive-surgical-mis-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Key Minimally Invasive Surgical Devices Market Insights

* The global Minimally Invasive Surgical Devices market was valued at USD 30.80 billion in 2024.
* Minimally Invasive Surgical Devices Market is projected to reach USD 53.26 billion by 2032.
* The Minimally Invasive Surgical Devices market is expected to grow at a CAGR of 7.13% during 2025-2032.
* North America currently represents the largest Minimally Invasive Surgical Devices market share.
* The Asia-Pacific region is anticipated to be the fastest-growing Minimally Invasive Surgical Devices market over the forecast period.
* The overall market structure is moderately concentrated, with a few major players holding significant shares.

Explore Custom Research Solutions tailored to your company's needs and unlock deeper intelligence on the USD 53.26 billion MIS devices market @ Minimally Invasive Surgical Devices Competitive Landscape [https://www.delveinsight.com/sample-request/minimally-invasive-surgical-mis-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Recent Industry Milestones (2022-2025)

* Launch of da Vinci 5 robotic system (Intuitive Surgical, 2024)
* FDA clearance of CardioVia ViaOne System for cardiac access (2025)
* CE mark for AdiMate liposuction system by NEOSYAD (France, 2025)
* FDA 510(k) clearance for Triopsy Medical's Integrated Biopsy System (2025)
* FDA IDE approval for EndoQuest's Endoluminal Surgical System pivotal trials (2025)

Minimally Invasive Surgical Devices Market Segmentation Analysis

Minimally Invasive Surgical Devices By Device Type

The surgical robotic systems category is expected to dominate in 2024. These systems provide surgeons with unmatched dexterity, tremor control, and 3D visualization, enabling complex procedures with millimeter-level precision. For example, the da Vinci 5 robotic platform by Intuitive Surgical, cleared by the U.S. FDA in 2024, represents a significant leap in robotic-assisted soft tissue surgery.

Other important device categories include electrosurgical devices, endoscopes, laparoscopes, neuroendoscopy systems, handheld instruments, and inflation devices, each supporting specific surgical needs.

Gain Exclusive Access to regional and device-level analysis - help your business stay ahead in the rapidly evolving surgical technology space @ Minimally Invasive Surgical Devices Market Size and Trends [https://www.delveinsight.com/report-store/minimally-invasive-surgical-mis-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Minimally Invasive Surgical Devices By Application

The cardiovascular application segment holds the largest market share. With cardiovascular diseases affecting nearly 500 million people worldwide, procedures such as transcatheter aortic valve replacement (TAVR), mitral valve repair, and robotic coronary artery bypass grafting (CABG) are increasingly being performed using MIS tools. The April 2025 FDA clearance of CardioVia's ViaOne System, a needle-free cardiac access device, underscores ongoing innovation in this segment.

Minimally Invasive Surgical Devices By End-User

Hospitals remain the dominant end-users, driven by the adoption of robotic and laparoscopic systems across specialties. Tertiary care institutions are integrating AI-powered visualization tools and robotic platforms to enhance surgical outcomes and streamline workflows. Ambulatory surgical centers are also witnessing growth due to rising outpatient procedures and patient preference for cost-effective care.

Minimally Invasive Surgical Devices Regional Insights

* North America Minimally Invasive Surgical Devices Market: Expected to hold the largest share, driven by a high prevalence of cancer and cardiovascular disorders, technological innovation, and robust R&D. For example, the U.S. anticipates 2.8 million new cancer cases by 2030, underscoring the need for advanced MIS solutions. The FDA's authorization of Virtual Incision's MIRA Surgical System in 2024 further highlights North America's leadership in device innovation.
* Europe Minimally Invasive Surgical Devices Market: Growth is supported by advanced healthcare infrastructure and government initiatives. The UK's NICE approval of robotic systems for 11 new surgical procedures in 2025 demonstrates the region's commitment to MIS adoption.
* Asia-Pacific Minimally Invasive Surgical Devices Market: The fastest-growing market, fueled by aging populations, rising surgical volumes, and expanding medical tourism. Notably, Olympus expanded the rollout of the iTind Trademark device for benign prostatic hyperplasia (BPH) across six APAC markets in 2025, improving patient access to advanced MIS solutions.

Minimally Invasive Surgical Devices Competitive Landscape

The minimally invasive surgical devices market is moderately concentrated, with global leaders such as Medtronic, Johnson & Johnson, Stryker, Intuitive Surgical, Boston Scientific, Abbott, Olympus, and KARL STORZ dominating through extensive portfolios and distribution networks.

At the same time, regional players and startups are carving niches by developing cost-effective and adaptable solutions, particularly in emerging economies. Strategic collaborations, acquisitions, and regulatory approvals are shaping competition. For example:

* Biobot Surgical received CE certification in 2025 for the Mona Lisa 2.0 robotic platform for prostate cancer diagnosis and treatment.
* Cleveland Clinic Abu Dhabi became the first in MENA to deploy the Artisse Intrasaccular Flow Modulator for brain aneurysms in 2025.
* Stryker strengthened its MIS portfolio by acquiring NICO Corporation, expanding into neurosurgical applications.

Minimally Invasive Surgical Devices Challenges and Opportunities

* Minimally Invasive Surgical Devices High costs - Advanced robotic systems and their maintenance remain expensive, limiting adoption in smaller hospitals and developing economies.
* Regulatory delays - Stringent approval pathways in the U.S. and Europe can slow commercialization of new technologies.
* Training gaps - Surgeons require extensive training to operate advanced robotic and AI-enabled systems, creating operational challenges.

However, opportunities are abundant. AI integration, single-port laparoscopic surgery, and natural orifice transluminal endoscopic surgery (NOTES) represent next-generation MIS technologies with vast potential. As healthcare systems prioritize efficiency and patient-centric outcomes, demand for MIS solutions is expected to accelerate further.

Speak to Our Analysts Today to understand how emerging MIS innovations can transform your strategic decisions @ Minimally Invasive Surgical Devices Companies and Manufacturers [https://www.delveinsight.com/sample-request/minimally-invasive-surgical-mis-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

The Role of Artificial Intelligence in Minimally Invasive Surgical Devices

Artificial Intelligence (AI) is increasingly integral to MIS. Platforms like Medtronic's Hugo Trademark robotic-assisted surgery system and Intuitive Surgical's da Vinci series leverage AI-driven analytics, augmented reality, and cloud connectivity to support surgical decision-making. AI enhances visualization, optimizes instrument placement, predicts complications, and personalizes surgical planning-ultimately improving outcomes and reducing recovery times.

Impact of U.S. Tariffs on Minimally Invasive Surgical Devices Market

Tariff increases on medical imports are impacting device costs and supply chains. Major players such as Johnson & Johnson and Medtronic reported tariff-related costs exceeding USD 400 million and USD 185 million respectively in 2025. Hospitals are reassessing procurement strategies, while manufacturers are shifting production and sourcing to mitigate risks. These dynamics may temporarily slow innovation but are also prompting companies to diversify supply chains and pursue cost-optimization strategies.

Analysts Commentry

The minimally invasive surgical devices market is undergoing a period of dynamic expansion, fueled by technological breakthroughs, growing patient demand, and strategic investments by leading manufacturers. With the market projected to surpass USD 53.26 billion by 2032, stakeholders across the value chain-from hospitals and healthcare providers to device manufacturers and policymakers-are poised to benefit from the transformative impact of minimally invasive surgical technologies.

About DelveInsight

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-minimally-invasive-surgical-devices-market-poised-to-reach-usd-5326-billion-by-2032-driven-by-rising-chronic-diseases-and-technological-advancements]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.